COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted (PAMVAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02647489
Recruitment Status : Completed
First Posted : January 6, 2016
Last Update Posted : June 26, 2018
University of Copenhagen
Université d'Abomey-Calavi
European Malaria Vaccine Initiative
Institut de Recherche pour le Developpement
Expres2ion Biotechnologies APS
Information provided by (Responsible Party):
University Hospital Tuebingen